Efficacy and Safety of Prolonged Dual Antiplatelet Therapy after Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients

OBJECTIVE: It remains controversial whether to extend the course of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). We conducted a study to investigate the benefits and risks of applying DAPT for different durations after PCI in acute coronary syndromes (ACS) patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Jialun, Zhang, Yi, Shi, Xiujin, Lin, Baidi, Zhang, Yunnan, Zhang, Ru, Wang, Yifan, Yan, Jialin, Lin, Yang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204726/
https://www.ncbi.nlm.nih.gov/pubmed/37228657
http://dx.doi.org/10.5334/gh.1185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10204726/
https://www.ncbi.nlm.nih.gov/pubmed/37228657
http://dx.doi.org/10.5334/gh.1185

Ejemplares similares